ReShape Lifesciences, Inc. (RSLS) Financials

RSLS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 7.8 million 4.7 million
2023-06-30 11.9 million 5.1 million
2023-03-31 11.1 million 7.5 million
2022-12-31 11.1 million 7.5 million

RSLS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.8 million 216000
2023-06-30 -6.7 million 218000
2023-03-31 -2.9 million 130000
2022-12-31 -2.9 million 130000

RSLS Net Income

No data available :(

RSLS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.4 million - 285000
2023-06-30 4.6 million - 307000
2023-03-31 3.9 million - 86000
2022-12-31 - - 171000

RSLS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 3.5 million
2023-06-30 3.2 million
2023-03-31 488254
2022-12-31 519198

RSLS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 542000 2.1 million 1.8 million
2023-06-30 36000 581000 2.4 million 2.2 million
2023-03-31 79000 441000 3.8 million 2.1 million
2022-12-31 79000 441000 5.9 million -

RSLS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.2 million 867000
2023-06-30 2.3 million 1.1 million
2023-03-31 3.1 million 1.5 million
2022-12-31 3.1 million 1.5 million

RSLS

Price: $0.17

52 week price:
0.14
4.10

Earnings Per Share: -38.56 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 32400

Market Capitalization: 3.9 million

Links: